Mexican Diabetes Therapy Market
Mexican Diabetes Therapy Market
RELEASE DATE
30-Oct-2008
30-Oct-2008
REGION
North America
North America
Research Code: N2DC-01-00-00-00
SKU: HC02057-NA-MR_07440
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02057-NA-MR_07440
Description
Currently in Mexico there are more than 10 million diabetics, from which only 20% is under correct control. Population growth and aging are some of the factors that keep increasing the potential for this market. Consequently increasingly more brands and products have been introduced into this market, splitting the diabetes therapy business in three segments: insulin, anti diabetes drugs and self monitoring accessories. Therefore, pharmaceutical companies face a tough competitive environment, in order to gain public and private healthcare sectors’ share.
Table of Contents
Market Introduction and Executive Summary
- Executive Summary
- Overview of the Mexican Healthcare System
- The Diabetes Business within the Mexican Pharmaceutical Market
Mexico – Diabetes Therapy Market
- Market Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
Market Forecast by Segment
- Insulin
- Antidiabetes Drugs
- Self-monitoring Accessories
Competitive Analysis and Market Share
- Insulin
- Antidiabetes Drugs
- Self-monitoring Accessories
Popular Topics
Currently in Mexico there are more than 10 million diabetics, from which only 20% is under correct control. Population growth and aging are some of the factors that keep increasing the potential for this market. Consequently increasingly more brands and products have been introduced into this market, splitting the diabetes therapy business in three segments: insulin, anti diabetes drugs and self monitoring accessories. Therefore, pharmaceutical companies face a tough competitive environment, in order to gain public and private healthcare sectors share.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N2DC-01-00-00-00 |
Is Prebook | No |